Biotage AB (publ) (BITGF) Stock Price, News & Analysis

Company Overview

Biotage AB (publ) is a Sweden-based life science company that develops, manufactures and sells solutions for the separation, purification and synthesis of molecules. Its products are used by pharmaceutical and biotechnology companies, academic institutions, contract research organizations and other laboratories involved in drug discovery, development and analytical testing.

The company’s portfolio includes automated purification systems, flash chromatography instruments and columns, solid-phase extraction products, evaporation systems and sample-preparation solutions. Biotage also provides technologies and consumables used in the purification and processing of peptides, oligonucleotides and other biomolecules, helping laboratories improve the efficiency and reproducibility of research workflows.

Biotage serves customers internationally through direct operations, distributors and sales channels across North America, Europe, Asia and other major life science markets. The company is headquartered in Uppsala, Sweden, and has built its business through the development and acquisition of laboratory technology platforms focused on analytical chemistry, organic chemistry and biomolecule purification.

Key Stats

• Today's Range: $15.01 to $15.01
• 50-Day Range: $15.01 to $15.01
• 52-Week Range: $8.77 to $18.52
• Volume: N/A
• Average Volume: 1,212 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BITGF
• CIK: N/A
• Web: www.biotage.com
• Phone: 46 18 56 59 00
• Fax: N/A
• Employees: 669
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A